Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 181,500 - -
Change - -20.69% -0.18% 2.67% 11.05% -16.69% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 205,439 202,457 198,767
Change - -20.41% 0.28% 1.92% 9.66% -7.57% -1.45% -1.82%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 30.9x 24x 21x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.79x 3.63x 3.44x
PEG - -36.9x -2x 0x -0.7x -3.48x 0.8x 1.5x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.62x 3.33x 3.12x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 4.09x 3.71x 3.41x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 15.8x 14x 12.5x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 17.5x 15.6x 13.9x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 27.2x 22.7x 20.7x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 3.67% 4.41% 4.83%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.57 2.741 2.898
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.45% 2.61% 2.76%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.389 4.374 4.986
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 75.8% 62.7% 58.1%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,198 54,525 58,249
EBITDA 1 12,815 12,485 10,188 10,635 11,735 12,985 14,467 15,891
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,721 13,019 14,316
Net income 1 7,071 6,933 5,723 13,402 6,524 6,162 7,843 8,710
Net Debt 1 7,801 6,891 7,783 6,509 4,407 23,939 20,957 17,267
Reference price 2 140.74 109.79 110.07 113.11 125.29 104.89 104.89 104.89
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,730,383 - -
Announcement Date 26/1/22 25/1/23 24/1/24 22/1/25 22/1/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
30.95x4.09x15.82x2.45% 181B
20.26x3.52x12.59x2.99% 116B
22.94x4.49x15.68x1.22% 113B
27.35x2.68x10.75x2.64% 79.83B
18.7x0.22x13.49x0.7% 65.06B
31.23x7.77x20x1.28% 54.35B
36.95x3.53x12.1x2.05% 52.23B
37.95x9.42x26.36x-.--% 44.15B
34.57x6.06x19.03x-.--% 32.47B
38.54x3.13x11.66x0.56% 32.12B
Average 29.94x 4.49x 15.75x 1.39% 77.07B
Weighted average by Cap. 28.06x 4.16x 15.20x 1.79%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Abbott Laboratories

Historical PBR trend

Valuation ratios - PBR - Abbott Laboratories

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Abbott Laboratories

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Abbott Laboratories


Year-on-year evolution of the Yield

Valuation ratios - Yield - Abbott Laboratories
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. Valuation Abbott Laboratories